Karin Eastham
Director at Veracyte, Inc. (VCYT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 22SEC | VCYTVeracyte, Inc. | Sell Plan | 3,20015,626 held (−17%) | $52.78 | $169K | -14.3% |
| Jun 22SEC | VCYTVeracyte, Inc. | Sell Plan | 52915,097 held (−3%) | $53.55 | $28K | -15.5% |
| Dec 8SEC | VCYTVeracyte, Inc. | Sell Plan | 6,39227,162 held (−19%) | $44.52 | $285K | +1.6% |
| Dec 8SEC | VCYTVeracyte, Inc. | Sell Plan | 12,80814,354 held (−47%) | $45.84 | $587K | -1.3% |
| Dec 8SEC | VCYTVeracyte, Inc. | Sell Plan | 80013,554 held (−6%) | $46.59 | $37K | -2.9% |
| Nov 7SEC | VCYTVeracyte, Inc. | Sell Plan | 9,67413,554 held (−42%) | $40.02 | $387K | +13.0% |
- Sell
Director Karin Eastham sold $169K of VCYT at $52.78 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Karin Eastham sold $28K of VCYT at $53.55 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Karin Eastham sold $285K of VCYT at $44.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Karin Eastham sold $587K of VCYT at $45.84 — cuts the stake by 47%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Karin Eastham sold $37K of VCYT at $46.59 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Karin Eastham sold $387K of VCYT at $40.02 — cuts the stake by 42%; pre-scheduled 10b5-1 plan sale.